The efficacy and safety of Sacubitril/Valsartan on pulmonary hypertension in hemodialysis patients

BACKGROUND: Pulmonary hypertension (PH) is a common complication of end-stage renal disease which is associated with adverse outcomes including all-cause mortality and cardiovascular events. Recent studies have demonstrated that Sacubitril/Valsartan (Sac/Val) as an enkephalinase inhibitor and angiot...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Cong, Guo, Yanhong, Wang, Yulin, Wang, Liuwei, Yu, Lu, Liang, Yan, Zhai, Zihan, Tang, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745023/
https://www.ncbi.nlm.nih.gov/pubmed/36523777
http://dx.doi.org/10.3389/fmed.2022.1055330

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745023/
https://www.ncbi.nlm.nih.gov/pubmed/36523777
http://dx.doi.org/10.3389/fmed.2022.1055330

Ejemplares similares